- The company responds to the tough economic conditions arising from the ongoing drought
- The waiver applies to members of the group ranches Oldonyonyokie, Shompole, Olkiramatian and Olkeri
- The waiver takes effect immediately to the end of December 2022
Tata Chemicals Company has responded to current challenges brought by the drought in Magadi with a waiver on medical services for the community.
The waiver is extended to children aged five years and under, expectant mothers, newborn babies, and new mothers (0-6 months of delivery) from now until the end of December 2022.
The company, according to the company’s MD and CEO Subodh Srivastav, may consider an extension of the offer depends on the situation on the ground at the end of the year.
“Our support and solidarity with the community as they go through the challenges brought about by the biting drought will enable them to spare their hard-earned income towards the other needs of the family,” said Srivastav on Tuesday evening.
Srivastav went on; “We have found this necessary to cushion the communities from the medical expenses they need during these hard times at the Tata Chemicals Magadi Hospital.”
He said the leadership of the company is delighted that they can make a direct contribution to keeping the children, their mothers and family healthy through the period of the drought.
The members of the four group ranches, Srivastav said, are encouraged to comply with the ongoing biometric registration to enjoy these waivers at the hospital.
Magadi Soda Hospital, supported by Tata Chemicals Magadi, is the only hospital within an area of an 80 km radius and has a wide catchment area with a population of about 30,000 people.
The Level Four hospital has 55-beds and strives to provide much-needed health care services to both employees and the surrounding community.
The Magadi Soda Hospital provides subsidised health care to the community and supports other health centres in the area, according to the company CEO.